Biotron Limited (ASX:BIT)
Australia · Delayed Price · Currency is AUD 0.0020
-0.0005 (-20.00%)
Jun 5, 2026, 1:05 PM AEST
Biotron Market Cap
Biotron has a market cap or net worth of 5.4 million as of June 5, 2026. Its market cap has increased by 1.78% in one year.
Market Cap
5.40M
Enterprise Value
3.76M
Revenue
-868.00
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since March 19, 2001, Biotron's market cap has decreased from 12.40M to 5.40M, a decrease of -56.42%. That is a compound annual growth rate of -3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 5.40M | -25.23% |
| Dec 31, 2025 | 7.23M | -55.50% |
| Dec 31, 2024 | 16.24M | -81.44% |
| Dec 29, 2023 | 87.52M | 259.40% |
| Dec 30, 2022 | 24.35M | -64.23% |
| Dec 31, 2021 | 68.09M | 24.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 11.48M |
| AdAlta | 10.62M |
| Invex Therapeutics | 8.27M |
| Vectus Biosystems | 7.69M |
| Bio-Gene Technology | 6.71M |
| Tissue Repair | 6.35M |
| Acrux | 6.16M |
| Zelira Therapeutics | 5.95M |